Summit Therapeutics cut to underperform from market perform; target lowered to $8.3 from $11.9
SMMT•Bernstein cut Summit Therapeutics to underperform from market perform and lowered its target price to $8.3 from $11.9.
Related News

From tarmac to APEC summit table, Japan's PM cuts a lonely figure
EWJ•

Nasdaq trade halt continues; reason not available at 03:58 am
HCHL•

Press digest: New York Times business news — November 19
GOOGL•

Oil prices rise as Middle East shipping attacks counter supply surplus outlook
USO•

Alibaba Q2 revenue rises on AI Cloud and Compute Services strength
BABA•